This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Murray CJ, Lopez AD . Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 1997 349: 1269–1276
Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P . Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease Lancet 1999 353: 1547–1557
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K et al . Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations Lancet 2000 355: 688–700
Pratt RE, Dzau VJ . Genomics and hypertension: concepts, potentials, and opportunities Hypertension 1999 33: 238–247
Winkelmann BR, Hager J . Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence Pharmacogenomics 2000 1: 73–94
Hwang DM, Dempsey AA, Wang RX, Rezvani M, Barrans JD, Dai KS et al . A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes Circulation 1997 96: 4146–4203
Meyer UA . Pharmacogenetics and adverse drug reactions Lancet 2000 356: 1667–1671
Evans WE, Relling MV . Pharmacogenomics: translating functional genomics into rational therapeutics Science 1999 286: 487–491
Bailey DS, Bondar A, Furness LM . Pharmacogenomics—it’s not just pharmacogenetics Curr Opin Biotechnol 1998 9: 595–601
Cargill M, Daley GQ . Mining for SNPs: putting the common variants—common disease hypothesis to the test Pharmacogenomics 2000 1: 27–37
Vineis P, Schulte P, McMichael AJ . Misconceptions about the use of genetic tests in populations Lancet 2001 357: 709–712
Rothstein MA, Epps PG . Ethical and legal implications of pharmacogenomics Nat Rev Genet 2001 2: 228–231
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amouyel, P. A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases. Pharmacogenomics J 1, 95–97 (2001). https://doi.org/10.1038/sj.tpj.6500027
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500027